0001104659-17-006179.txt : 20170202
0001104659-17-006179.hdr.sgml : 20170202
20170202170359
ACCESSION NUMBER: 0001104659-17-006179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170201
FILED AS OF DATE: 20170202
DATE AS OF CHANGE: 20170202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1030 MASSACHUSETTS AVE.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 1030 MASSACHUSETTS AVE.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KARSEN PERRY A
CENTRAL INDEX KEY: 0001260573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 17569147
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
a4.xml
4
X0306
4
2017-02-01
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001260573
KARSEN PERRY A
C/O JOUNCE THERAPEUTICS, INC.
1030 MASSACHUSETTS AVENUE
CAMBRIDGE
MA
02138
1
0
0
0
Common Stock
2017-02-01
4
P
0
5000
16.00
A
5000
D
/s/ Anna L. Barry, Attorney-in-fact
2017-02-02